Posts

capillus hair loss

Capillus Light Therapy Cap Featured in Modern Salon Magazine

Capillus Light Therapy Cap Featured in Modern Salon Magazine

Modern Salon magazine has featured Capillus LLC, during their annual HAIR + Summit live event dedicated to helping salon professionals provide their clients with solutions for hair loss and thinning.

The story focuses on how Capillus laser therapy caps play a major role for stylist and salon clients in the reversal of hair loss due to androgenetic alopecia.

The article, which appeared in the magazine’s online platform, highlights Capillus by stating: “In an intimate breakout session, Capillus shared details on their Stylist Program, offering their laser therapy caps designed to prevent progression of hair loss and regrow thinning hair.”

As Carly Klein, national educator for Capillus states in the article: “Up until recently, Capillus laser therapy caps were only cleared for sale by the FDA through medical professionals,” Klein continues, “Our Stylist Program means we can now be sold through salons and stylists, too.”

In addition to highlighting Capillus’s hair restoration efforts, this year’s HAIR + Summit featured the new comfortable flexible fit Capillus cap with continuous wave light delivery. This new advancement vastly reduces the users wear time from 30 minutes every other day to 6 minutes daily.

The new technology now provides users with a continuous wave output for a faster treatment. All Capillus mobile laser therapy caps are available for legal distribution by salons and stylists as per FDA clearance.

For a link to the article click here.

Readers are invited to visit https://www.capillus.com to learn more about Capillus hair regrowth products and laser therapy medical devices.

To learn more about the Capillus Stylist Program visit https://www.capillus.com/stylists.

About Capillus, LLC

Capillus, LLC offers prescription and over-the-counter hair regrowth products and medical devices for both men and women suffering from hair loss. The Capillus premiere product lines include low-level laser therapy (LLLT) devices that are FDA-cleared and manufactured in the US under the highest-quality certification standard for the medical device industry (ISO13485).

Capillus also offers additional non-prescription clinical hair products for hair and scalp health. Capillus products are available directly to the public for at-home use and also to their network of physicians for office use. For more information visit http://www.capillus.com.

Source

Capillus Announces Grand Opening of the First Capillus Store in Hong Kong

The CapillusRX Newest Innovation In Hair Restoration

Capillus, LLC To Unveil Its Newest Innovation In Hair Restoration Laser Technology, The CapillusRX

Capillus, LLC has announced the release of CapillusRX™ Laser Therapy Cap with an industry leading 312 diodes. The new flex fitting cap has the most number of lasers and simultaneous coverage of any laser cap device on the market, offering 40 more lasers than the Capillus272 Pro™.

The device is the first laser therapy cap to be introduced with 6-minute daily treatment sessions. Capillus will unveil the CapillusRX™ at the International Society of Hair Restoration Surgeon’s Conference next week in Prague.

“We see the CapillusRX™ as a new generation of laser! We’re rolling out the most powerful laser device on the market today, in the same discreet design. Our device has 312 diodes, all fitted snugly into a new and comfortable hypoallergenic base.

Not only are we offering physicians a powerful laser cap, it’s also what we feel is the most comfortable,” says Carlos Pina, Founder and CEO of Capillus, LLC.

With the advent of continuous wave output technology, the CapillusRX™ requires the user to wear the cap for only six-minutes per day.

This is a vast improvement over the previous model, which needed to be worn 30-minutes on alternate days, making it now easier than ever for user compliance.

With continuous wave technology, the diode lifetime of the CapillusRX™ is also increased by 30%. Providing a steady power output to the laser diodes guarantees steadier diode energy output.

capillus capCapillusRX™ provides unparalleled, flexible comfort and is adaptable to different head sizes and shapes. Although the number of diodes have increased in the CapillusRX™ hat, there is no change in technology or indication of use. Therefore, there is no change to the product’s Food and Drug Administration (FDA) clearance.

The CapillusRX™ will not be sold directly to consumers as the company’s other models (Capillus82™, Capillus202™, Capillus272 Pro™). The CapillusRX™ model is only available exclusively through the Capillus physician network.

CapillusRX™ will be showcased for the first time at the International Society of Hair Restoration Surgery (ISHRS) conference in Prague, Czech Republic October, 4-7, 2017.

Readers are invited to visit https://www.capillus.com to learn more about Capillus hair regrowth products and laser therapy medical devices.

About Capillus, LLC

The Miami, Florida-based company, Capillus, LLC offers prescription and over-the-counter hair regrowth products and medical devices for both men and women suffering from hair loss. The Capillus premiere product lines include low-level laser therapy (LLLT) devices that are FDA-cleared and manufactured in the US under the highest-quality certification standard for the medical device industry (ISO13485).

Capillus also offers additional non-prescription clinical hair products for hair and scalp health. Capillus products are available directly to the public for at-home use and also to their network of physicians for office use.

For more information visit http://www.capillus.com.

Source

capillus

Published Clinical Study Shows Capillus Laser Therapy Safe and Effective at Treating Female Androgenetic Alopecia

Published Clinical Study Shows Capillus Laser Therapy “Safe and Effective” at Treating Female Androgenetic Alopecia

A peer-reviewed study authored by Dr. Shelly Friedman, D.O., F.A.O.C.D. and supported by Patricia Schnoor, BSBA, confirms that low-level laser therapy (LLLT) with Capillus® may play a considerable role in the treatment of androgenetic alopecia for females, given the impartial evidence illustrating favorable hair regrowth results.

The research was published in the June 2017 edition of Dermatologic Surgery, the official journal of the American Society for Dermatologic Surgery, encouraging familiarity of LLLT as a practical method of fighting hair loss at home within the greater medical community.

Dr. Friedman of the Scottsdale Institute for Cosmetic Dermatology is a board-certified hair restoration surgeon with nearly three decades of experience treating over 15,000 patients with hair loss.

Patricia Schnoor is the head of quality assurance and governmental affairs at Capillus, overseeing the assembly, testing and quality control for Capillus’ line of FDA-cleared at-home laser caps.

The study’s circulation is expected to pave access to new international markets, allowing more individuals to undergo laser therapy hair loss treatment by way of physician prescription or recommendation.

“Performing and publishing clinical research under the rigor of a prestigious journal is of critical importance for doctors prescribing under evidence based practice guidelines,” said Fernando Bermúdez, Director of International Distribution at Capillus. “Published data is also a reference for increasingly savvy consumers wanting to make an educated purchase decision before committing to a long-term treatment.”

The purpose of this randomized controlled trial was to outline the effects of photobiomodulation, or laser light, on the hair follicle and surrounding tissues in patients suffering from hair loss. The subjects consisted of 44 healthy females ages 18 to 60 years who were recruited at two separate board–approved treatment sites.

The Capillus272™ Pro was used in the study under the alias of a “handi-dome” laser device. Using the discreet dome insert with laser diodes operating at 650 nm, active participants receiving LLLT with the Capillus272 Pro™ showed a 51 percent mean increase in hair counts compared to patients who used a seemingly identical yet defunct device.

The researchers concluded that low-level laser treatment administered for 30 minutes every other day for 17 weeks is both safe and effective in treating androgenetic alopecia in healthy females between the ages of 18 to 60 with Fitzpatrick skin Types I to IV and Ludwig–Savin Baldness Scale I-2 to II-2 baldness patterns.

No side effects or adverse reactions were reported by any subject at any time during the study.

For more, view the published abstract on Dermatologic Surgery, June 2017 – Volume 43 – Edition 6.

About Capillus

Capillus proudly offers hair regrowth products and medical devices recommended by hair restoration physicians around the world for both men and women with hair loss.

Capillus’s premiere product lines include low level laser therapy (LLLT) devices that are FDA-Cleared and manufactured in the USA under the highest quality certification standard for the medical device industry (ISO13485).  Capillus272 Pro, Capillus 202, and Capillus82 are light-weight and battery-operated laser therapy caps for at-home hair loss treatment, used 30 minutes every other day and worn discreetly under a sports cap.

The Capillus272 OfficePro is for laser therapy sessions administered in salons and clinics for clients seeking introductory treatment.  Capillus laser therapy devices feature more lasers than any other FDA-Cleared clinical device on the market for non-presrciption sale. Capillus offers additional products for clinical hair therapy and scalp health as well as keratin hair fibers for temporary concealment of thin hair. Readers are invited to visit http://www.capillus.com to learn more about Capillus hair regrowth products and laser therapy medical devices.

Source